Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
Clinical trial NCT00609817 · TERMINATED
Trial details
- NCT number
- NCT00609817
- Sponsor
- La Jolla Pharmaceutical Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.